NYSE:PRGO Perrigo Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Perrigo Company PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $45.67 +0.04 (+0.09 %) (As of 09/29/2020 12:00 AM ET) Add Compare Share Today's Range$45.25Now: $45.67▼$46.1150-Day Range$44.99MA: $50.46▼$54.7652-Week Range$40.01Now: $45.67▼$63.86Volume602,911 shsAverage Volume1.05 million shsMarket Capitalization$6.23 billionP/E Ratio26.25Dividend Yield1.97%Beta1.16 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The firm operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the U.S., Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with consumer-focused businesses in the U.K. and Australia. The Prescription Pharmaceuticals commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingPerrigo has received a consensus rating of Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $59.00, Perrigo has a forecasted upside of 29.2% from its current price of $45.67.Amount of Analyst CoveragePerrigo has only been the subject of 1 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesPerrigo has received 739 “outperform” votes. (Add your “outperform” vote.)Underperform VotesPerrigo has received 719 “underperform” votes. (Add your “underperform” vote.)Community SentimentPerrigo has received 50.69% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote “Outperform” if you believe PRGO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PRGO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend YieldPerrigo pays a meaningful dividend of 1.97%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthPerrigo has only been increasing its dividend for 1 years.Dividend CoverageThe dividend payout ratio of Perrigo is 22.33%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Perrigo will have a dividend payout ratio of 20.79% next year. This indicates that Perrigo will be able to sustain or increase its dividend. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Perrigo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $149,912.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 0.30% of the stock of Perrigo is held by insiders.Percentage Held by Institutions83.52% of the stock of Perrigo is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Perrigo are expected to grow by 5.87% in the coming year, from $4.09 to $4.33 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Perrigo is 26.25, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.72.Price to Earnings Ratio vs. SectorThe P/E ratio of Perrigo is 26.25, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.10.Price to Book Value per Share RatioPerrigo has a P/B Ratio of 1.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 4.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.71 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals SectorMedical Current SymbolNYSE:PRGO Previous Symbol CUSIP71429010 CIK1585364 Webwww.perrigo.com Phone353-1709-4000Debt Debt-to-Equity Ratio0.60 Current Ratio2.05 Quick Ratio1.49Price-To-Earnings Trailing P/E Ratio26.25 Forward P/E Ratio11.17 P/E GrowthN/A Sales & Book Value Annual Sales$4.84 billion Price / Sales1.29 Cash Flow$6.50 per share Price / Cash Flow7.03 Book Value$42.64 per share Price / Book1.07Profitability EPS (Most Recent Fiscal Year)$4.03 Net Income$146.10 million Net Margins4.73% Return on Equity10.05% Return on Assets5.06%Miscellaneous Employees11,200 Outstanding Shares136,480,000Market Cap$6.23 billion Next Earnings Date11/4/2020 (Estimated) OptionableOptionable $45.67 +0.04 (+0.09 %) (As of 09/29/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive PRGO News and Ratings via Email Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter. Perrigo (NYSE:PRGO) Frequently Asked Questions How has Perrigo's stock price been impacted by COVID-19? Perrigo's stock was trading at $46.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PRGO shares have decreased by 0.8% and is now trading at $45.67. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Perrigo? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Perrigo. When is Perrigo's next earnings date? Perrigo is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020. View our earnings forecast for Perrigo. How were Perrigo's earnings last quarter? Perrigo Company PLC (NYSE:PRGO) announced its quarterly earnings data on Wednesday, August, 5th. The company reported $1.03 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.87 by $0.16. The company earned $1.22 billion during the quarter, compared to the consensus estimate of $1.23 billion. Perrigo had a return on equity of 10.05% and a net margin of 4.73%. The firm's revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.86 earnings per share. View Perrigo's earnings history. How often does Perrigo pay dividends? What is the dividend yield for Perrigo? Perrigo declared a quarterly dividend on Wednesday, July 29th. Stockholders of record on Friday, August 28th will be given a dividend of $0.225 per share on Tuesday, September 15th. This represents a $0.90 annualized dividend and a dividend yield of 1.97%. The ex-dividend date is Thursday, August 27th. View Perrigo's dividend history. What guidance has Perrigo issued on next quarter's earnings? Perrigo updated its FY20 earnings guidance on Thursday, September, 17th. The company provided EPS guidance of $3.95-4.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.02. What price target have analysts set for PRGO? 7 Wall Street analysts have issued twelve-month price objectives for Perrigo's stock. Their forecasts range from $53.00 to $70.00. On average, they expect Perrigo's share price to reach $59.00 in the next twelve months. This suggests a possible upside of 29.2% from the stock's current price. View analysts' price targets for Perrigo. Are investors shorting Perrigo? Perrigo saw a increase in short interest during the month of August. As of August 14th, there was short interest totaling 4,340,000 shares, an increase of 11.3% from the July 30th total of 3,900,000 shares. Based on an average trading volume of 848,400 shares, the days-to-cover ratio is presently 5.1 days. View Perrigo's Short Interest. Who are some of Perrigo's key competitors? Some companies that are related to Perrigo include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Horizon Therapeutics (HZNP), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Mylan (MYL), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX), Corcept Therapeutics (CORT) and Supernus Pharmaceuticals (SUPN). View all competitors. What other stocks do shareholders of Perrigo own? Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN). Who are Perrigo's key executives? Perrigo's management team includes the following people: Mr. Murray S. Kessler, CEO, Pres & Director (Age 59)Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 59)Mr. Jeffrey R. Needham, Exec. VP & Pres of Consumer Healthcare Americas (Age 63)Mr. Svend Andersen, Exec. VP & Pres of Consumer Healthcare International (Age 57)Mr. Ronald L. Winowiecki, Advisory (Age 53) What is Perrigo's stock symbol? Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO." How do I buy shares of Perrigo? Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Perrigo's stock price today? One share of PRGO stock can currently be purchased for approximately $45.67. How big of a company is Perrigo? Perrigo has a market capitalization of $6.23 billion and generates $4.84 billion in revenue each year. The company earns $146.10 million in net income (profit) each year or $4.03 on an earnings per share basis. Perrigo employs 11,200 workers across the globe. What is Perrigo's official website? The official website for Perrigo is www.perrigo.com. How can I contact Perrigo? Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected] This page was last updated on 9/29/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
